Information-based methods in the development of antiparasitic drugs

Parasitology Research

Volumn 90, Issue SUPPL. 2, 2003, Pages

  Wolf, Kristina ^a   Dormeyer, Matthias ^a  

^a 4SC AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; RISEDRONIC ACID; SC 0006738; TRYPANOTHIONE REDUCTASE; UNCLASSIFIED DRUG;

COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG ACTIVITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARASITOSIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

ANIMALS; ANTIPARASITIC AGENTS; COMPUTER SIMULATION; DIPHOSPHONATES; DRUG DESIGN; ENZYME INHIBITORS; GLUTATHIONE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MODELS, MOLECULAR; NADH, NADPH OXIDOREDUCTASES; SOFTWARE; SPERMIDINE; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA;

EID: 0037625372     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-002-0773-6     Document Type: Review

References (26)

1. Allen FH, Kennard O (1993) 3D search and research using the Cambridge structural database. Chem Des Auto News 8:130-137
2. Aronov AM, Verlinde CLMJ, Hol WGJ, Gelb MH (1998) Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure based design. J Med Chem 41:4790-4799
3. Aronov AM, Suresh S, Buckner FS, Van Voorhis WC, Verlinde CLMJ, Opperdoes FR, Hol, WGJ, Gelb, MH (1999) Structure-based design of submicromolar, biological active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A 96:4273-4278
4. Avery MA, Alvim-Gaston M, Rodrigues CR, Barreiro EJ, Cohen FE, Sabnis YA, Woolfrey JR (2002) Structure-activity relationships of the antimalarial agent artemisinine. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. 45:292-303
5. Böhm HJ (1992) LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6:61-78
6. Bond CS, Zhang Y, Berriman M, Cunningham ML, Fairlamb AH, Hunter WN (1999) Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione and the structure based discovery of new natural product inhibitors. Structure 7:81-89
7. Bressi JC, Verlinde CLMJ, Aronov AM, Shaw ML, Shin SS, Nguyen LN, Suresh S, Buckner FS, Van Voorhis WC, Kuntz ID, Hol WGJ, Gelb MH (2001) Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure based drug design. J Med Chem 44:2080-2093
8. Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids on carrier proteins. J Am Chem Soc 110:5959-5967
9. Hansch C, Fujita T (1964) A method for the correlation on biological activity and chemical structure. J Am Chem Soc 86:1616-1626
10. Jacoby EM, Schlichting I, Lantwin CB, Kabsch W, Krauth-Siegel RL (1996) Crystal structure of the Trypanosoma cruzi trypanothione reductase-mepacrine complex. Proteins 24:73-80
11. Jones G, Wilett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727-748
12. Klebe G (1998) Comparative molecular similarity indices analysis: CoMSIA. Perspect Drug Discov Des 12:87-104
13. Kramer B, Metz G, Rarey M, Lengauer T (1999) Ligand docking and screening with FlexX. Med Chem Res 9:463-478
14. Krieger S, Schwarz W, Ariyanayagam MR, Fairlamb AH, Krauth-Siegel RL, Clayton C (2000) Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol 35:542-552
15. Kuntz ID, Blanly JM, Oatley SJ, Langridge R, Ferrin TEA (1982) A geometric approach to macromolecule ligand interactions. J Mol Biol 161:269-288
16. Li R, Chen X, Gong B, Selzer PM, Li Z, Davidson E, Kurzban G, Miller RE, Nuzum EO, McKerrow JH, Fletterick RJ, Gillmor SA, Craik CS, Kuntz ID, Cohen FE, Kenyon, GL (1996) Structure-based design of parasitic protease inhibitors. Bioorg Med Chem Lett 4:1421-1427
17. Martin MB, Grimley JS, Lewis JC, Heath HT, Bailey BN, Kendrick H, Yardley V, Caldera A, Lira R, Urbina JA, Moreno SN, Docampo R, Croft SL, Oldfield E (2001) Trypanosorna brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii and Plasmodium falciparum: a potential route to chemotherapy. J Med Chem 44:909-916
18. Martin MB, Sanders JM, Kendrick H, de Luca-Fradley K, Lewis JC, Grimley JS, van Brussel EM, Olsen JR, Meints GA; Burzynska A, Kafarski P, Croft SL, Oldfield E (2002) Activity of bisphosphonates against Trypanosoma brucei rhodesiense. J Med Chem 45:2904-2914
19. Morris GM, Goodsell DS, Halliday Huey R, Hart W, Belew RK, Olson AJ (1998) Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639-1662
20. Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470-489
21. Rarey M, Kramer B, Lengauer T (1997) Protein-ligand docking based on incremental construction without manual intervention. J Comput Aided Mol Des 11:369-384
22. Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508-1514
23. Rodigues CR, Flaherty TM, Springer C, McKerrow JH, Cohen FE (2002) CoMFA and HQSAR of acylhydrazide cruzain inhibitors. Bioorg Med Chem Lett 12:1537-1541
24. Schneider G, Böhm H-J (2002) Virtual screening and fast automated docking methods. Drug Discov Today 7:64-70
25. Waiters WP, Stahl MT, Murcko MA (1998) Virtual screening - an overview. Drug Discov Today 3:160-178
26. Xu D, Xu Y, Uberbacher EC (2000) Computational tools for protein modeling. Curr Protein Pept Sci 1: 1-21